Showing 661 - 680 results of 41,690 for search '(( a point decrease ) OR ( 50 ((((ns decrease) OR (we decrease))) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664
  5. 665

    Optimal screening time point for a single colonoscopy program in the US. by Viktor Zaika (18611072)

    Published 2024
    “…<p><b>(A)</b> Reduction in life years lost, CRC incidence, mortality and total costs for different time points of a single screening colonoscopy with 100% adherence. …”
  6. 666

    Optimal time points for a three-colonoscopy screening program in the US. by Viktor Zaika (18611072)

    Published 2024
    “…Selected model parameters were increased and decreased by up to 50%. Dashed lines indicate average optimal points obtained for nominal simulations. …”
  7. 667
  8. 668

    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

    Published 2021
    “…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”
  9. 669
  10. 670
  11. 671
  12. 672
  13. 673

    GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

    Published 2017
    “…The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”
  14. 674
  15. 675

    A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation <i>In Vivo</i> and Regulates Urethral Tension by Hiroshi Saga (584103)

    Published 2014
    “…To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 <i>in vivo</i>. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation.…”
  16. 676
  17. 677
  18. 678
  19. 679
  20. 680